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Abstract
Background: Asthma is a chronic inflammatory disease with a strong genetic predisposition. A major challenge for
candidate gene association studies in asthma is the selection of biologically relevant genes.
Methodology/Principal Findings: Using epithelial RNA expression arrays, HapMap allele frequency variation, and the
literature, we identified six possible candidate susceptibility genes for childhood asthma including ADCY2, DNAH5, KIF3A,
PDE4B, PLAU, SPRR2B. To evaluate these genes, we compared the genotypes of 194 predominantly tagging SNPs in 790
asthmatic, allergic and non-allergic children. We found that SNPs in all six genes were nominally associated with asthma
(p,0.05) in our discovery cohort and in three independent cohorts at either the SNP or gene level (p,0.05). Further, we
determined that our selection approach was superior to random selection of genes either differentially expressed in
asthmatics compared to controls (p=0.0049) or selected based on the literature alone (p=0.0049), substantiating the
validity of our gene selection approach. Importantly, we observed that 7 of 9 SNPs in the KIF3A gene more than doubled the
odds of asthma (OR=2.3, p,0.0001) and increased the odds of allergic disease (OR=1.8, p,0.008). Our data indicate that
KIF3A rs7737031 (T-allele) has an asthma population attributable risk of 18.5%. The association between KIF3A rs7737031 and
asthma was validated in 3 independent populations, further substantiating the validity of our gene selection approach.
Conclusions/Significance: Our study demonstrates that KIF3A, a member of the kinesin superfamily of microtubule
associated motors that are important in the transport of protein complexes within cilia, is a novel candidate gene for
childhood asthma. Polymorphisms in KIF3A may in part be responsible for poor mucus and/or allergen clearance from the
airways. Furthermore, our study provides a promising framework for the identification and evaluation of novel candidate
susceptibility genes.
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Introduction
The amount of genetic information available with high
throughput screens has increased exponentially in the last decade,
with the potential for information on three billion base pairs being
available through genome wide sequencing. While the genome
wide approach has been successfully used to identify numerous
genetic variants associated with complex human diseases [1], most
variants identified so far confer relatively small increments in risk,
and explain only a small proportion of disease heritability. This
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23714has led to considerable speculation regarding the sources of the
‘‘missing heritability’’ [2]. Common diseases such as asthma are
heterogeneous and may actually be a compilation of disorders with
numerous subphenotypes. Current studies are not designed to
examine specific subphenotypes of disease due to the large sample
sizes required for genome wide approaches. Genome wide
approaches require thousands of cases and controls to have
sufficient power to properly evaluate such associations. As with
many complex diseases such as asthma, analysis of large sample
sizes made up of heterogeneous phenotypes may make it more
difficult to identify true associations. By focusing on regions with a
priori evidence of gene involvement, the candidate gene approach
has the advantage of requiring smaller sample sizes as fewer
statistical tests are performed. One of the major challenges of the
candidate gene approach for genetic studies is selection of
appropriate genes for evaluation. Methods that have been utilized
thus far include selection of genes based on published biologic
function, findings from mouse models of asthma, and chromo-
somal location in ‘hot-spots’ that have been linked to disease
phenotypes in genome wide association studies (GWAS) and
linkage studies. While over 600 studies have used these strategies
to identify more than 120 different genes to be associated with
asthma or its related phenotypes, only a limited number of genes
have been replicated leaving much variation yet unexplained [3].
Another promising strategy to narrow the numerous potential
disease-associated genes in a less biased way involves examining
differences in allele frequencies between populations in conjunc-
tion with differences in gene expression within relevant cell types
or tissues [4]. Inclusion of an analysis of allele frequency
differences between populations may be a beneficial strategy for
any disease that shows significant differences in prevalence
between groups. A recent study by Frank et. al [5] integrated
global gene expression arrays, DNA sequence variation arrays,
and public databases to identify new previously untested candidate
genes for further testing. This more targeted approach allows
researchers to reduce the overall number of genes to be tested and
hence increases statistical power to detect an association by
lowering the multiple testing burden.
The overall objective of our study was to develop an innovative
approach for identifying candidate genes for genetic association
studies with complex diseases including asthma. We combined the
unbiased characteristics typically obtained using GWAS or
expression arrays with the more focused quality of traditional
literature-based candidate gene approaches. The basis of our
resulting approach takes advantage of our previously published
evaluation of nasal epithelial cell-derived RNA from asthmatic and
non-allergic children [6], population differences in asthma preva-
lence, tagging SNPs in the HapMap database, and the published
literature. Importantly,nasalepithelial cell samples wereused asour
source tissue, because of their ability to interface with and function
as a physical barrier to the environment, their importance in
initiating the immune response to environmental triggers and their
role in modulating allergic inflammation [7,8]. Further, compared
to collection of bronchial lavage fluid or bronchial biopsies, nasal
epithelial cell collection is less invasive and has been shown to be a
good surrogate for the lower airway epithelium [9,10].
Using our approach, we identified five novel genes that had not
been previously implicated in asthma and a sixth gene (PDE4B)
that was recently linked to asthma (Table 1) [11]. Upon analysis,
we determined that all six genes were nominally associated with
pediatric asthma in our discovery population (p,0.05). SNPs in a
single gene, KIF3A, were significant even after considering multiple
comparisons (p,0.0001). Our results substantiate the validity of
our candidate gene selection approach.
Methods
Ethics
The study protocol was approved by the Cincinnati Children’s
Hospital Medical Center Institutional Review Board. Parents gave
written informed consent for the children’s participation, and
children gave their assent.
Table 1. Selected genes and functions.
#SNPs
a Gene Full Gene Name Chr.
Array
Findings
b Reported Processes and Function
c
Reported Associated
Diseases
9 KIF3A kinesin family
member 3A
5q31 Down protein binding, ATP binding,
microtubule motor activity,
nucleotide binding
53 DNAH5 dynein, axonemal,
heavy polypeptide 5
5p15 Down microtubule motor activity, ATP
binding, ATPase activity,
nucleotide binding
primary ciliary dyskinesia,
ciliary motility disorders
68 ADCY2 adenylate cyclase 2 5p15 Down adenylate cyclase activity, magnesium
ion binding, phosphorus-oxygen
lyase activity
7 PLAU plasminogen
activator,
urokinase
10q24 Up kinase activity, peptidase activity,
plasminogen activator activity,
serine-type endopeptidase activity
acantholysis, alzheimers
rheumatoid arthritis,
cancer, endometriosis
53 PDE4B phosphodiesterase
4B
1p31 Up 39,59-cyclic-AMP phosphodiesterase
activity, 39,59-cyclic-nucleotide
phosphodiesterase activity, catalytic
activity, hydrolase activity
chronic kidney
failure, schizophrenia
4 SPRR2B small proline-rich
protein 2B
1q21 Up structural molecule activity,
keratinization
aIndicates the total number of genotyped SNPs.
bIndicates the direction of gene expression of uncontrolled asthmatics versus non-allergic controls.
cObtained from Gene Ontology website (www.geneontology.org).
doi:10.1371/journal.pone.0023714.t001
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The discovery population consisted of a subset of 4 to 17 year
old Caucasian participants enrolled in either the Greater
Cincinnati Pediatric Clinic Repository (GCPCR) or the Genomic
Control Cohort (GCC), a cohort supported by the Cincinnati
Children’s Hospital Medical Center (CCHMC). The GCPCR
includes over 6,200 patients with various diagnoses visiting
CCHMC outpatient specialty clinics, the Emergency Department
or recruited from the community. Participants completed
questionnaires, and provided buccal or saliva samples for genetic
analyses. The GCC includes over 1,080 children recruited to be
representative of the Greater Cincinnati area. All GCC partici-
pants completed a questionnaire that included asthma, allergy and
skin questions similar to those included in GCPCR and provided a
blood sample for genetic analysis. Non-asthmatic/non-allergic
control children were not proactively recruited into the GCPCR
for this study due to the availability of appropriate GCC controls.
GCC asthmatics were not included in the analyses of the discovery
cohort, because their asthma diagnoses were based on parent
report alone. Inclusion criteria and case-control definitions are
described in Table 2.
In addition to our discovery population, four additional
populations were used to replicate our findings (see Table 2).
Cincinnati-based African American children selected from the
GCPCR and GCC were identified as described in our discovery
Caucasian population. Cases for a second Greater Cincinnati
Caucasian population consisted of children with parent-
reported asthma from the GCC and compared to the Cincinnati
Control Cohort (CCC), a population based cohort of Caucasian
adults with no personal or family history of asthma (by self-
report) representative of Greater Cincinnati.with no personal or
family history of asthma (by self-report) from a population-based
representative adults sample from Greater Cincinnati. These
controls were chosen because we could conclusively indicate
their absence of pediatric and adult asthma, unlike similar aged
controls that may develop asthma with age. Genotyping data
from Affymetrix 6.0 SNP chip was also available for the GCC
a n dC C C .T h et h i r da n df o u r t hp o pulations consisted of Banked
DNA was utilized for genotyping of Puerto Ricans and
Mexicans parent- child trios with banked DNA for genotyping
participating in the Genetics of Asthma in Latino Americans
(GALA) Study [12], a multicenter international collaborative
effort designed to identify clinical and genetic risk factors
associated with asthma.
DNA Isolation and Genotyping
Genomic DNA was isolated from buccal swabs with either the
Zymo Research Genomic DNA II Kit (Zymo Research Corp.,
Orange, CA) or the Purgene DNA Purification System (Gentra
Systems Minneapolis, MN), and from Oragene saliva samples
per the kit’s instructions. Alternatively, genomic DNA was
extracted from blood samples using Manual PerfectPure DNA
Blood Kit (Invitrogen, Carls b a d ,C A ) .G e n o t y p i n gf r o m
discovery cases and controls and African American samples
was performed using a custom Illumina Golden Gate assay
according to manufacturer’s protocol (http://www.illumina.
com; San Diego, CA). Genotypes were assigned using Bead-
Studio’s genotyping module (BeadStudio v3.2, San Diego, CA).
For GALA, genotyping of KIF3A rs7737031 was accomplished
using the Roche LightTyper 480 (Roche Diagnostics, India-
napolis, IN) and the KIF3A rs7737031 using TaqMan SNP
Genoptyping Assay (assay ID C_25973778_10; Applied Biosys-
tems, Foster City, CA).
Statistical Analysis
Genetic Association. SNPs failing Hardy Weinberg
Equilibrium in the non-allergic control group (p,0.0001),
having minor allele frequencies below 10%; or missing call rates
greater than 10% were excluded. In addition, individuals with
more than 20% of their total SNPs missing were excluded.
Principal component analyses were performed using the 30
included ancestry-informative markers (AIMs) and the computer
program EIGENSTRAT [13,14] to account for potential
population stratification. When examining the 194 SNPs in the
six genes, the genomic inflation factor was 1.0, suggesting minimal
impact of population stratification for these 30 AIMs. Therefore,
no population stratification adjustment was required for analyses
of asthmatics versus non-allergic controls in the discovery or
African-American populations likely due to the fact that selection
of the study population was from a single geographic region.
However, the first principal component score was included as a
covariate in comparisons of allergic versus non-allergic children in
the discovery population as the genomic inflation factor was
greater than 1.0 (l=1.33 before adjustment and l=1.02 after
adjustment). Using PLINK [15], associations with asthma were
tested adjusting for age and gender using the additive logistic
regression model stratified by race. To address multiple testing, we
first determined the average pairwise LD (a measured by r
2) for all
SNP combinations (160 SNPs, correlation=0.13) and using this
correlation, calculated the Bonferroni correction using the freely
available Simple Interactive Statistical Analyses Software (http://
www.quantitativeskills.com/sisa/). Associations were therefore
considered significant at or below the 0.0006 level. For our
second Caucasian population, six of the seven SNPs were imputed
from the AffymetrixH 6.0 SNP data using MACH and HapMap
CEU (release 22) as the reference [16,17]. Imputed KIF3A SNPs
were tested for association with asthma status again using additive
logistic regression models in PLINK. The family-based association
test (FBAT) [18] was used to assess associations between KIF3A
rs7737031 and asthma in the GALA trios. Mexican and Puerto
Rican samples were analyzed independently. HWE was tested in
parents only. The population attributable risk for KIF3A
rs7737031 was estimated using the R software package pARccs
(v0.2–2; www.r-project.org) [19].
SNP Imputation. Estimation of SNPs not genotyped in the
study was performed to increase statistical power as well as to
detect novel associations
26. Based on HapMap CEU results
(release 22), imputation was performed after filtering out SNPs
with genotyping call rates ,10%, minor allele frequencies ,10%,
and HWE p-value,0.0001 using MACH 1.0.16 (http://www.sph.
umich.edu/csg/MaCH), which uses a hidden Markov model to
estimate an underlying set of unphased genotypes for each subject.
We only considered SNPs that could be imputed with relatively
high quality (RSQ.0.4). For the replication populations and
validation of our approach, the available Affymetrix 6.0 SNP chip
genotype data (http://www.ncbi.nlm.nih.gov/gap) from the
populations described above were used. Imputed SNPs were
tested for association with asthma status using PLINK software as
described above.
Validation. To test whether FST is a proxy for minor allele
frequency (MAF), we estimated Spearman correlation coefficients,
as the MAF and FST were not normally distributed. For the
comparison of SNPs with high and low FST values, pair-wise FST
was determined using Python (http://www.python.org) scripts and
HapMap data [20]. We selected 24 genes containing SNPs with
the largest FST values (range 0.25–0.73) and 24 genes containing
SNPs with the lowest FST values (range 0.00–0.10). We performed
a case control analysis between self-reported child asthmatics from
Novel Method Identifies Six Asthma Candidate Genes
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Population
Race or
Ethnicity
Population
Source(s)
#
asthmatics
#
allergic
#
controls
Determination
of race or
ethnicity
Asthma
inclusion
criteria
Allergic
inclusion
criteria
Control
inclusion
criteria
Discovery Caucasian Greater
Cincinnati
Pediatric Clinic
Repository
(GCPCR), CCHMC
Genomic
Control
Cohort (GCC)
312 220 246 Race was self-
reported and
ascertained by
questionnaire;
both the participant
and his/her parents
must have been
identified themselves
as Caucasian/White;
all subjects were
non-Hispanic
Children 4–17
years old with
confirmed
physician
diagnoses of
asthma based
on clinical
examination,
available
pulmonary
function test
results and
respiratory
symptom
scores at
a CCHMC-
based
specialty
clinic
Non-asthmatic
children ages
4–17 years
old with
physician
diagnosed
allergic rhinitis
or atopic
dermatitis
based on
radioallergosorbent
testing or skin
prick allergy
testing; or children
with a personal
history of either
environmental
allergies,
hay fever or
eczema
Non-allergic
Caucasian
controls
were those
children
ages 4–17 years
old
that did not meet
the criteria to be
either an
asthmatic
or allergic case,
had
no personal
history
of food allergies
and
no family history
(parents and
siblings) of
asthma
Replication African-
American
GCPCR, GCC 182 129 39 Race was
self-reported
and ascertained
by vquestionnaire;
both the participant
and his/her parents
must have been
identified
themselves as
African American
/Black; all subjects
were non-Hispanic
See Discovery
Caucasian
population
above
See Discovery
Caucasian
population
above
See Discovery
Caucasian
population
above
Caucasian GCC, Cincinnati
Control Cohort
(CCC)
74 NA
a 211 Parents of asthmatics
reported their
children to be
Caucasian by
questionnaire;
adult controls
similarly reported
their race to be
Caucasian by
questionnaire
Caucasian children
ages 4 to 18 years
with parent-
reported
asthma from a
population-
based
representative
sample
from Greater
Cincinnati
NA Caucasian adults
ages 24 to 90
years
with no personal
or
family history of
asthma (as
determined by
self-report) from
a population-
based
representative
sample from
Greater
Cincinnati
Puerto
Rican
Genetics of
Asthma in
Latino Americans
(GALA) Study
398 NA 712 Ethnicity was
self-reported and
ascertained by
questions; both
biological parents
and all biological
grandparents of
asthmatics had to
be identified as
being of Puerto
Rican ethnicity
Index children at
least 8 years of
age with physician
diagnosed asthma
(confirmed by
hospital-based
medical chart
review) and two
or more
parent-reported
asthma symptoms
(among wheezing,
coughing, and
shortness
of breath) in the last
2 years were
enrolled over a 4-
year period
in the San Francisco
Bay Area, California,
New York City, New
York , Puerto Rico,
and Mexico City,
Mexico
NA One or both
biological
parents
of index
asthmatic
children were
enrolled; allergic
status was not a
criteria for
inclusion
or exclusion
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of asthma from the GCC (n=226) using all Affymetrix 6.0 SNPs
within 1000 kb of these genes. We then tested whether SNPs with
high FST values (FST$0.1) are more likely to show association with
asthma (p#0.05) than SNPs with low FST values (FST=0). To test
whether our gene selection strategy was superior to random
selection, we again evaluated the available Affymetrix data from
the 74 GCC asthmatics and 238 CCC controls. From this analysis,
four of our six genes exhibited significant evidence of association
(p#0.05). Results from this analysis were then utilized to select six
genes from the 161 differentially regulated genes using a random
number generator. We noted how many of the six genes had at
least one SNP with nominal association (p#0.05). We repeated
this analysis 10,000 times. To determine the empirical level of
significance, we determined how many times the random selection
obtained evidence in at least four genes added one and divided by
the number of replicates (10,000).
Gene Expression Studies
Balb/c mice (Jackson Labs; Bar Harbor, ME) were sensitized
twice intraperitoneally with 10 mg house dust mite (HDM,
Dermatophagoides pteronyssinus; Greer Laboratories, Lenoir, NC) in
100 ml phosphate buffered saline (PBS) or 100 ml of PBS alone,
and then challenged intratracheally with 100 mg HDM in 50 ml
PBS or 50 ml PBS alone, euthanized 24 hours later, lung RNA
extracted in TRIzol (Invitrogen, Carlsbad, CA) and cDNA
prepared (Superscript First Strand cDNA synthesis kit; Invitrogen,
Carlsbad, CA). Quantitative PCR on mouse and human cDNA
samples collected previously [6] were performed using the Roche
Light Cycler 480 SYBR Green 1 Master kit (Mannheim,
Germany). The annealing temperature for primers sets was
60uC and the extension time was 5 seconds. After amplification,
values from KIF3A were normalized to respective housekeeping
genes values (glyceraldehyde 3-phosphate dehydrogenase
(GAPDH)o ractin). Primers used to amplify both human and
mouse KIF3A include: Forward- 59-GGAGGAGACGAGCT-
GAG-39; Reverse- 59-CTCTGACTTTGCAGCCA-39. Primers
used to amplify human GAPDH: Forward- 59-AAATCCCAT-
CACCATCTTCC-39; Reverse- 59-TCACACCCATGACGAAC-
A-39. Primers used to amplify mouse actin: Forward - 59-
GGCAATGCGGCTGCAA-39; Reverse- 59-GGGTACCCACG-
CGAATCAC-39. For the human epithelial gene expression
studies, statistical analysis was performed using PRISM software
(GraphPad Software Inc., La Jolla, CA) using one-way ANOVA
followed by a Tukey-Kramer post-hoc test (for statistical
significance between groups). For comparisons showing significant
differences, precise p-values were calculated using a two-tailed t-
test comparing the two groups under consideration. In the mouse
studies, statistical significance was determined using a two-tailed t-
test in PRISM.
Results
Gene Selection Approach
We previously published a RNA expression study in nasal
epithelial samples from uncontrolled and controlled pediatric
asthmatics compared to non-allergic controls [6]. The results of
our study revealed that compared to the non-allergic control group
(n=4), the mean gene expression levels of 161 genes (142 known
genes) were consistently up or down regulated in the group of
uncontrolled asthmatics (n=4) (one-way ANOVA ; p,0.01)
(Fig. 1). To further reduce the pool of 161 candidate genes
identified, we compared allele frequencies of SNPs within these
genes in two distinct populations shown to have large differences in
population prevalence of asthma. We hypothesized that specific
alleles in genes with large inter-population frequency differences
might be partly responsible for observed variations in asthma
susceptibility. In fact, a recently published genome-wide estimation
of the fixation index (FST), a measure of population differentiation
devised by Wright [21,22], on approximately 4 million SNPs from
the HapMap project, found that genes associated with complex
diseases showed a significantly higher mean value of FST
suggesting that population genetic differentiation, particularly in
genes associated with complex diseases may explain discrepancies
in disease prevalence between different populations [23].
For our analysis, we used Wright’s FST to quantify genetic
differentiation between the Phase I HapMap CEU (Utah residents
with Northern and Western European ancestry, n=60) and the
CHB (Han Chinese in Beijing, China, n=45). We selected these
populations based on the largest reported disparity in asthma
prevalence in the ISAAC report [24] available at the time among
the four Phase I HapMap populations ($10% asthma prevalence
for Caucasians vs. ,5% for Chinese, respectively). FST was
calculated for individual SNPs (FST=(p12p2)
2/(4p(12p)), where p1
is the allele frequency in the Caucasian population, p2 is the
frequency of the same allele in the Han Chinese population and p
is the average allele frequency of each allele across each population
[25,26]. As FST has a theoretical minimum of 0 indicating no
genetic differences, and a theoretical maximum of 1 indicating
fixation for alternative alleles, we hypothesized that genes with
Population
Race or
Ethnicity
Population
Source(s)
#
asthmatics
#
allergic
#
controls
Determination
of race or
ethnicity
Asthma
inclusion
criteria
Allergic
inclusion
criteria
Control
inclusion
criteria
Mexican GALA 300 NA 585 Ethnicity was
self-reported and
ascertained by
questionnaire;
both biological
parents of asthmatic
children and all
biological grandparents
had to be identified
as being of Mexican
ethnicity
See Puerto Rican
population above
NA See Puerto
Rican population
above
aNot applicable.
doi:10.1371/journal.pone.0023714.t002
Table 2. Cont.
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prevalence are more likely to be associated with disease. Using this
approach, we identified 16/161 genes (or 14/142 known genes)
showing differential expression between cases and controls to have
relatively large differences in allele frequencies in least one SNP
(FST$0.25; Fig. 1).
Next, these 16 genes were subjected to an extensive literature
review using publicly available databases such as PubMed. Our
investigation revealed that six of these genes (PDE4B, SPRR2B,
ADCY2, KIF3A, DNAH5, and PLAU; see Table 1) were located in
chromosomal regions that had been previously linked to asthma or
other allergic disease phenotypes and had been shown to be
regulated during allergic inflammation [1] (Table 1). Furthermore,
we identified five of the same six genes (ADCY2, DNAH5, KIF3A,
PDE4B, SPRR2B) when substituting FST values calculated using
the HapMap CEU and YRI (Yorubans from Ibadan, Nigeria)
populations for the CEU and CHB populations.
Tagging SNP Selection
Consequently and independent of the SNPs evaluated in our
analysis of FST, a total of 172 tagging SNPs were selected for
inclusion on a custom Illumina Golden Gate platform for the six
genes of interest using Haploview and Tagger (http://www.broad.
mit.edu/mpg/haploview). All tagging SNPs included were re-
quired to have minor allele frequencies greater than 0.05 and
patterns of linkage disequilibrium (LD; r
2.0.8) in the public
HapMap Phase I CEU and YRI populations (http://hapmap.
ncbi.nlm.nih.gov) [27,28,29].The rationale for using tagging SNPs
is that genetic variants that are near each other and in LD tend to
be inherited together as a result of shared ancestry. The strong
correlations between markers within haplotype blocks help to
enable accurate representation of a gene region by a small number
of tagging SNPs and further ensures the efficient capture all the
common genetic variation in the genes selected. We selected SNPs
from the CEU and YRI populations because our discovery
population consisted of children of Caucasian ancestry, and the
availability of African American children for a replication cohort.
We also included an additional 18 non-synonymous SNPs, four
promoter SNPs, and 30 unlinked ancestry-informative markers
(AIMs) [30] to estimate global population structure. AIMs were
selected based on the criterion previously described by Rosenberg
et al., 2003 [30]. Twenty of these AIMs were included to
specifically distinguish between Northern and Southern Europeans
[31] and the remaining ten AIMs were chosen to specifically
distinguish between Europeans and people of African descent.
Asthma and Allergic Disease Genetic Associations
Genotyping was performed first on 790 Caucasian children
from the Cincinnati Metropolitan area. Our SNP call rate was
uniformly .95%. SNPs with call rates ,10% (N=9) or minor
allele frequencies ,10% (N=25) were removed from the analysis.
None of the SNPs failed Hardy-Weinberg Equilibrium in the non-
allergic control population (p,0.001). When the more conserva-
tive cut off of 0.01 was used, only three additional SNPs would
have been excluded. Individuals with more than 20% of their total
SNPs missing were also excluded from the analysis (N=12;
Table 3). The mean age of the remaining children was slightly, but
significantly less for asthmatic (p=3.9610
29) and allergic
Figure 1. Novel unbiased approach to identify candidate asthma susceptibility genes. The approach consisted of three stages with an
evaluation of RNA expression of 14,500 genes in nasal epithelial samples in stage 1. Next, 142 known genes with .3-fold difference between
uncontrolled asthmatics and non-allergic controls (P,0.05) were taken forward to stage 2. In stage 2, using HapMap data, the allelic frequencies of
Caucasians (Utah residents of European ancestry; CEU) and the Han Chinese (Beijing, China; CHB) were compared and 14 known genes with a fixation
index (FST).0.25 were identified. Six of these genes, which mapped to chromosomal regions that had been linked to asthma previously, were
included in the next phase. In stage 3, tagging SNPs including all CEU and YRI (Yoruban residents of Ibadan, Nigeria) SNPs with minor allele frequency
less than 0.05 in the 6 genes were genotyped in children with asthma, allergic rhinitis or atopic dermatitis without asthma, and in non-allergic control
children using a custom Illumina Golden Gate SNP Chip. Seven SNPs in a single gene, KIF3A, were significantly associated with asthma after adjusting
for multiple comparisons (p-value,0.0006).
doi:10.1371/journal.pone.0023714.g001
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26) children compared to the non-allergic control
group (Table 3).
Using a case-control study design, associations with asthma
were evaluated. Notably, seven of nine KIF3A SNPs were
associated with asthma with more than a 2-fold increase in the
odds ratio for asthma (p,10
24) even after applying an LD
adjusted Bonferroni correction for 160 pairwise comparisons with
0.13 correlation (a=6 610
24; Table 4). We retrospectively
compared the FST estimates of differentiation between HapMap
(Phase III, Build 26) CEU and CHB populations for each of the
KIF3A SNPs genotyped (Table 4). Our analysis revealed that all
seven of the asthma-associated KIF3A SNPs had FST values$0.32,
while the remaining 2 SNPs had much lower FST estimates,
suggesting that FST may be useful in identifying those SNPs most
likely to be associated with asthma. Interestingly, at least one
genetic variant in each of the six identified epithelial genes was
nominally associated with asthma at p-value,0.05 (Fig. 2A).
To further verify our findings and substantiate the approach, we
evaluated associations with asthma in 362 African American
children also from the Cincinnati Metropolitan area. We found
that ADCY2, PDE4B, DNAH5 and KIF3A were again associated
with asthma (p,0.05) at the gene level (Fig. 2B). Interestingly,
seven KIF3A SNPs were also significantly associated with other
allergic diseases such as allergic rhinitis and eczema (p-
values#0.008 and p-value#0.023, respectively) in both our
discovery Caucasian and African American populations (Table 4).
In both our discovery Caucasian and our African American
populations, asthma was diagnosed according to ATS criteria [32]
by hospital-based specialists at CCHMC. In order to validate the
results we had obtained from these subsets, we utilized childhood
and adult population-based cohorts for which Affymetrix 6.0 gene
chip genome-wide genotyping data was available. We evaluated
associations between our candidate genes and parent reported
diagnosis of asthma in 74 Caucasian childhood asthmatics and 211
adults with no personal or family history of asthma living in
Cincinnati. We performed imputation analysis to directly assess
associations of tagging SNPs previously genotyped in our discovery
Caucasian population as well as other SNPs not previously
genotyped. Our analysis revealed all 7 previously associated KIF3A
SNPs (as well as several other imputed SNPs) were significantly
Table 3. Characteristics of the discovery Caucasian population.
Asthmatic Children Allergic Children Non-allergic Controls
Total children, N 317 227 246
Children after exclusions, N
a 312 220 246
Mean age (years)6 SD 10.0463.44
b 10.2163.54
b 11.7963.40
Male gender, N (%) 170 (54.5) 126 (57.3%) 121(49.2)
aIndicates the number children after children with missing call rates above 20% were removed.
bIndicates significant differences (p,0.05) with non-allergic control children.
doi:10.1371/journal.pone.0023714.t003
Table 4. KIF3A SNP associations with asthma.
Population= Discovery Caucasian
a African-American
a
Secondary
Caucasian
b
Puerto
Rican
c Mexican
c
# cases/# controls= 312/246 182/39 74/211 398 300
KIF3A SNP
Major/Minor
Allele FST
e OR P-value OR P-value OR P-value P-value P-value
rs12186803 G/A 0.33 2.08 0.00011 1.79 0.032 3.21 0.005
rs1080001 A/G 0.32 2.08 0.00009 1.83 0.029 2.76 0.011
rs7737031 C/T 0.34 2.18 0.00003 1.83 0.028 2.76 0.011 0.0458 0.471
rs9784675 A/G
d 0.33 2.09 0.00007 1.61 0.064 3.32 0.002
rs3798130 G/A
d 0.33 2.16 0.00004 1.56 0.086 3.21 0.005
rs2299011 C/G
d 0.32 2.19 0.00003 1.52 0.101 3.21 0.005
rs12514685 C/T
d 0.32 2.16 0.00004 1.52 0.100 2.76 0.011
rs1468216 G/A 0.01 0.78 0.16870 0.68 0.191 1.08 0.810
rs17691077 A/C 0.06 0.85 0.41000 - - - -
aThe discovery Caucasian population and African American population consisted of asthmatic children from the GCPCR and non-asthmatic/non-allergic controls from
the GCPCR and GCC. Associations between asthmatics and controls were tested using an additive model. Odds ratios (OR) were determined using logistic regression
based on the minor allele after adjusting for age, gender and population stratification. Bolding indicates the SNP associations ,0.05. 7 of 9 SNPs were significant even
after considering multiple comparisons (p,0.0006).
bThe Secondary Caucasian population consisted of asthmatic children from the GCC and non-asthmatic adult controls from the CCC. OR and p-values were determined
using HapMap CEU results (release 22) and Affymetrix data from each cohort for imputation analysis.
cThe Puerto Rican and Mexican populations consisted of mother, father, child trios enrolled in the GALA Study. The value provided is the frequency of childhood
asthmatics within those trios.
dMajor and minor alleles are reversed in African Americans;
eValue of fixation index (FST) between CHB (China/Beijing) and CEU (Caucasian Europe, as represented by Utah) HapMap populations.
doi:10.1371/journal.pone.0023714.t004
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Furthermore, at least one previously associated SNP within
ADCY2 and DNAH5 was associated with asthma (Fig. 3A). Imputed
SNPs within PDE4B not previously genotyped were also
significantly associated with asthma.
We next examined associations between imputed SNPs and
asthma in 398 Puerto Rican and 300 Mexican family trios enrolled
in the Genetics of Asthma in Latino Americans (GALA) Study
[12]. Puerto Ricans living in the US have higher asthma
prevalence (26%), morbidity, and mortality rate than Caucasians
Figure 2. Genetic associations with childhood asthma. A. We evaluated associations in our discovery Caucasian population between asthma
and 160 directly genotyped SNPs within the six epithelial genes using the additive model after adjusting for age and gender. The upper dashed line
corresponds to a p-value of 0.0006, the Bonferroni adjustment after considering LD correlation between SNPs. SNPs significant at this level (all in
KIF3A) include rs12186803 (p=0.00011), rs3798130 (p=0.00004), rs2299011 (p=0.00003), rs12514685 (p=0.00004), rs7737031 (p=0.00003),
rs1080001 (p=0.00009), and rs9784675 (p=0.00007). The lower dashed line corresponds to a p-value of 0.05. SNPs significant at this level include
rs11747117 (p=0.0188), rs7714830 (p=0.0219), and rs13174121 (p=0.0113) in ADCY2, rs2896111 (p=0.0335) and rs17263496 (p=0.0136) in DNAH5,
rs12060491 (p=0.0369) in PDE4B, rs6693927 (p=0.0496) in SPRR2B and rs2227562 (p=0.0044) in PLAU. B. Associations between asthma and 160
directly genotyped SNPs within the six epithelial genes were evaluated among African American children from Cincinnati using an additive model
after adjusting for age and gender. The dashed line corresponds to a p-value of 0.05. SNPs significant at this level include rs11742602 (p=0.038),
rs2017214 (p=0.014) and rs1032719 (p=0.048) in ADCY2, rs30168 (p=0.030) in DNAH5, rs11208834 (p=0.032) in PDE4B, rs12186803 (p=0.032),
rs1080001 (p=0.029) and rs7737031 (p=0.028) in KIF3A.
doi:10.1371/journal.pone.0023714.g002
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PLoS ONE | www.plosone.org 8 August 2011 | Volume 6 | Issue 8 | e23714Figure 3. Associations with asthma in three additional independent populations. SNPs not genotyped in the study were imputed based
on HapMap CEU results (release 22) with MACH software using the available from the Affymetrix 6.0 genotype data. Imputed SNPs were then tested
for associations with asthma using PLINK. The dashed line corresponds to a p-value of 0.05. A. Associations in a second Cincinnati-based Caucasian
population. B. Asthma associations in the GALA Puerto Rican trios. C. Associations in the GALA Mexican trios.
doi:10.1371/journal.pone.0023714.g003
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asthma prevalence (10%), morbidity, and mortality rate
[33,34,35,36,37,38]. Our analysis provided evidence for gene
level replication of ADCY2, DNAH5, KIF3A, and PDE4B (Fig. 3B,
C, respectively). As only KIF3A achieved significance after
correction for multiple testing, this replication is essential to
minimize false positive findings. To further support our findings,
we directly genotyped KIF3A rs7737031, the SNP with the most
significant association in our discovery population, and again
observed a significant association with asthma in the Puerto Rican
(p-value=0.0458), but not the Mexican trios (p-value=0.471)
(Table 4).
Validation of Candidate Gene Selection
To validate our approach, we tested whether identifying
candidate genes based on higher values of FST is a proxy for
identifying more common SNPs with more power to detect an
association, or whether information is gained from measures of
population differentiation. We found that FST values for the 161
differentially expressed genes in uncontrolled asthma were not
significantly correlated with minor allele frequency (Spearman
rho=0.05, p-value=0.52), suggesting that including measures of
FST to identify candidate genes is not simply identifying SNPs with
greater power to detect an association, but rather provides
information beyond that of minor allele frequency.
Second, we compared the HapMap CEU and CHB populations
and determined whether SNPs with high FST values were more
likely to exhibit association with asthma than those SNPs with low
FST values. We evaluated Affymetrix 6.0 data of 74 asthmatic and
238 non-allergic control children from Cincinnati. Of the 161
differentially regulated genes identified by our expression array, we
determined that the 241 SNPs within the 24 genes with the highest
FST values (FST$0.1; including SNPs within the final six genes
selected - KIF3A, ADCY2, DNAH5, PDE4B, PLAU, SPRR2B) were
significantly more likely (p=0.0008, Fisher’s Exact Test; 6% of
SNPs reached p#0.05) to be associated with asthma than the 190
SNPs in the 24 genes with the lowest FST values (FST=0; 0.5% of
SNPs reached p#0.05).
Finally, again using the Affymetrix 6.0 data of the 74 Caucasian
asthmatic children and 238 control children described above, we
randomly selected six genes among those differentially expressed
in asthmatics versus controls and asked how often we would
observe at least four of the six genes having at least one SNP
significantly associated with asthma (p-value=0.05). Notably, we
found that the random selection of genes using differences in
expression alone was superior to our proposed selection approach
(e.g. fewer genes were identified using random selection) in only 48
out of 10,000 permutations (p=0.0049), and conclude that the
addition of FST and the published literature search together
provides a valuable tool for candidate gene selection.
RNA Expression Analyses
As we found the most significant results with KIF3A and as our
earlier expression array findings indicate that KIF3A expression
was down-regulated in nasal epithelial children with acute asthma
[6], we wanted to corroborate this observation. To this end,
quantitative PCR for KIF3A was performed on nasal epithelial
RNA samples from the asthmatic children and controls previously
included on the array (Fig. 4). Consistent with our array data, we
observed that KIF3A expression was significantly down-regulated
(p,0.05). As an additional independent validation of our results,
we also measured expression of KIF3A in lung RNA isolated from
a house dust mite-induced murine asthma model. Our results
indicate that KIF3A expression is significantly reduced compared
to phosphate buffered saline-treated controls [6] (Fig. 4).
Discussion
A major challenge for candidate gene association studies is the
selection of biologically relevant genes for evaluation. Our unique
approach utilized multiple lines of evidence to select relevant
candidate genes (Fig. 1). First, as nasal epithelial cells have been
previously shown to be a good surrogate for bronchial epithelial
cells [10], we took advantage of expression microarray data from
these cells to identify genes differentially expressed in asthmatics
and non-asthmatic controls. Next, using HapMap, we compared
the allelic variation across each of these genes in populations with
marked differences in asthma prevalence (CEU vs. CHB),
reviewed the published literature to identify specific genes having
potential application in the lung and genotyped tagging SNPs
Figure 4. KIF3A gene expression of human epithelial RNA from
children with uncontrolled asthma and of mouse models with
asthma is decreased compared to controls. Gene expression of
KIF3A in nasal epithelial-derived RNA from non-allergic children,
controlled and uncontrolled asthmatics was determined by quantitative
PCR. GAPDH was used to normalize for expression. To induce an
asthma-like phenotype, wild type Balb/c mice were sensitized and
challenged with 100 mg of house dust mite (asthma model) and
compared to mice sensitized and challenged with phosphate buffered
saline (control). One day post-treatment, RNA was extracted from lungs
and gene expression measured by quantitative PCR. Actin was used to
normalize for gene expression.
doi:10.1371/journal.pone.0023714.g004
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within six genes were associated with asthma (Fig. 2A). Many of
these associations were also observed in one or more of our 4
independent populations either at the SNP or gene level (Fig. 2B
and Fig. 3), and the association with KIF3A was associated in three
of four populations examined in addition to our discovery
population. The Puerto Rican and Mexican GALA trios not only
allowed us to evaluate our results across racial/ethnic groups, but
to evaluate genetic associations in populations with potentially
different environmental exposures.
For candidate gene selection, researchers have used gene
expression results [6], FST [21,22], and biologic relevance as
gleaned from the literature [1], but no study has combined these
strategies. We found that the combination of approaches for
candidate gene selection was superior to using one type of data.
Indeed, in an independent screen of SNPs in genes found to have
dysregulated epithelial gene expression in uncontrolled asthmatics,
we found that SNPs with high FST values were more likely to be
associated with asthma than those with low FST values, including
the six genes evaluated in this study, supporting the validity of our
gene selection approach. Further, when we randomly selected
genes from those that were differentially expressed, we found our
selection method was statistically superior. These data point to a
strong relationship between epithelial cells and asthma and
substantiate the validity of this approach to identify genetic
biomarkers of complex disease. Collectively, our approach may be
applicable to other complex diseases that show varying preva-
lences across human populations, and may be a useful tool to select
novel gene candidates for assessment of disease associations in
other pertinent cell types and tissues.
Using this approach, we have identified KIF3A as a possible
susceptibility gene for childhood asthma and allergic disease. We
found that seven of nine KIF3A SNPs genotyped were significantly
associated with asthma in our discovery Caucasian population and
in independent Caucasian and African American populations – all
from Cincinnati (Table 4). SNPs in KIF3A were also to a lesser
degree, associated with other allergic diseases independent of
asthma demonstrating the importance of appropriate phenotyping
and selection of controls in genetic studies of asthma (Table 5). If
we had merely compared asthmatics to non-asthmatics without
determining the non-asthmatics allergic status, we might have
missed the association with KIF3A. Importantly, all of the disease
associated KIF3A SNPs and neither of the two non-associated
KIF3A SNPs displayed significant population differentiation in
HapMap CEU and CHB populations (individual FST val-
ues.0.25; Table 4). The observed association was strongest for
KIF3A rs7737031 which had a PAR for asthma of .18%. Carriers
of rs7737031 have more than double the odds of having asthma.
Similar to the PAR of this KIF3A variant, the PAR for myocardial
infarction was 21% in individuals with the previously reported
rs10757278 variant located in adjacent CDKN2A and CDKN2B
genes [39]. We also directly genotyped this SNP and evaluated its
association with asthma in Puerto Rican and Mexican populations
in the GALA Study. Puerto Ricans and Mexicans living in the US
have higher and lower asthma prevalences, morbidity, and
mortality rates than Caucasians, respectively. Interestingly, our
analysis reveals that KIF3A rs7737031 was significantly associated
in Puerto Ricans and not Mexicans.
KIF3A is a heterotrimeric member of the kinesin superfamily of
microtubule associated motors that are important in the transport
of protein complexes within cilia and flagella [40,41] among other
roles. Cilia, together with mucus and the airway surface liquid
layer, make up the mucociliary apparatus that clears inhaled
allergens or other particles from the lung. Defective mucociliary
clearance is a characteristic feature of several genetically linked
airway diseases including asthma and cystic fibrosis [42,43], yet
the mechanisms responsible for poor mucus and/or allergen
clearance from the airways remain largely unknown.
As KIF3A is located on 5q31, immediately upstream of IL-4,w e
also noted a strong LD between IL-4 and KIF3A SNPs in our
discovery cohort, a finding that is consistent with another
published report [44]. Examination of International HapMap
data [45] indicates that this LD exists across many other
populations as well making it difficult to determine if one or both
genes confer risk. Numerous studies have reported associations
with IL-4, asthma and other allergic diseases [29,46]. It is possible
that some of the previous asthma associations reported between
asthma and IL-4 may reflect the LD with KIF3A. Therefore, we
further examined the biologic plausibility of KIF3A as an asthma
susceptibility gene by examining gene expression in the lungs of
mice. We found expression of KIF3A was significantly reduced in
HDM-treated mice compared to controls (Fig. 4). We speculate
that in asthmatics specifically, diminished KIF3A expression might
be important in allowing the lung to repair itself after
exacerbation. Alternatively, diminished KIF3A expression may
contribute to the lungs’ inability to clear mucus and remove
inhaled particles and aeroallergens therefore exacerbating the
asthma and/or allergic phenotypes. Individuals with polymorphic
cilia genes may have further reduced cilia gene expression,
diminished ciliary function and increased allergen exposure
resulting in even greater susceptibility to asthma and allergic
disease. Regardless of the mechanism of action, KIF3A is clearly
down-regulated in asthma, supporting a role for this novel gene in
the pathogenesis of this disease. While our analyses of tagging
SNPs provide strong evidence of a gene-disease association, it will
be important to investigate the combined effects of IL-4 and KIF3A
in future studies and to identify specific causal variants in
Table 5. KIF3A SNP associations with allergic disease.
KIF3A Allergic vs. Non-allergic Controls
a
Discovery
Caucasian
African
American
Frequency cases/controls= 220/246 129/39
SNP
Major/Minor
Allele OR P-value OR P-value
In Caucasians
rs12186803 G/A 1.84 0.003 2.11 0.013
rs1080001 A/G 1.84 0.003 2.11 0.013
rs7737031 C/T 1.83 0.004 2.11 0.013
rs9784675 A/G
b 1.72 0.008 2.13 0.009
rs3798130 G/A
b 1.83 0.003 1.89 0.023
rs2299011 C/G
b 1.82 0.003 1.92 0.017
rs12514685 C/T
b 1.82 0.004 1.85 0.023
rs1468216 G/A 0.70 0.076 0.78 0.416
rs17691077 A/C 0.91 0.661
aThe discovery Caucasian population and African American population
consisted of asthmatic children from the GCPCR and non-asthmatic/non-
allergic controls from the GCPCR and GCC. Associations between allergic
children and controls were tested using an additive model. Odds ratios (OR)
were determined using logistic regression based on the minor allele after
adjusting for age, gender and population stratification. Bolding indicates the
SNP associations ,0.05.
bIndicates major and minor alleles are reversed in African Americans.
doi:10.1371/journal.pone.0023714.t005
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multiple genes and critically exploring the biological relevance of
genes previously unknown to influence disease susceptibility.
In summary, our study took advantage of our previously
published evaluation of nasal epithelial cell-derived RNA from
asthmatic and non-allergic children [6], population differences in
asthma prevalence, tagging SNPs in the HapMap database, and
the published literature to identify six genes (ADCY2, DNAH5,
KIF3A, PDE4B, PLAU, SPRR2B) for detailed and targeted genetic
testing. The most strongly associated gene, KIF3A, was first
reported by our group as having a role in asthma in 2009 [47].
KIF3A has also been associated with aspirin sensitive asthma [48].
Here, we verify that KIF3A is a novel candidate gene for childhood
asthma and show that its expression is down regulated in nasal
epithelial cells in asthmatics. Our success supports the validity of
our approach for identifying asthma candidate genes with a high
likelihood of exhibiting association in specific variants. As the level
of genomic data continues to increase, it will be imperative to
develop methods which can help focus studies. By demonstrating
that we can identify associations using this approach and that these
associations can be replicated, we have provided a novel
framework for the identification of candidate genes.
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